The EGFR Mutation Test industry has experienced significant growth in recent years and is projected to continue its upward trajectory in the coming years. The EGFR Mutation Test is a genetic test that helps identify mutations in the epidermal growth factor receptor (EGFR) gene. These mutations are commonly found in various types of cancer, including lung cancer.
The main purpose of the EGFR Mutation Test is to provide valuable information for cancer treatment decisions. By identifying specific EGFR mutations in a patient's tumor, healthcare professionals can determine the most appropriate treatment approach, such as targeted therapies or personalized medicine. This test plays a crucial role in improving patient outcomes and enabling precision medicine.
According to the report by HJResearch, the global EGFR Mutation Test market is expected to reach a size of US$738.7 million by 2022, with a compound annual growth rate of 13.7%. This growth can be attributed to several factors, including an increasing prevalence of cancer worldwide, growing awareness about personalized medicine, and advancements in genetic testing technologies.
Cancer hospitals and clinical research institutes are the primary end-users of EGFR Mutation Test. These institutions rely on the test results to guide treatment decisions and conduct research studies on EGFR mutations. The demand for EGFR Mutation Test is expected to remain high in these settings as the understanding of cancer genomics continues to evolve.
The global market for EGFR Mutation Test is highly competitive, with several major manufacturers leading the industry. Some of the key players in this market include Abbott, Merck, Thermo Fisher Scientific, Illumina, BioMerieux, QIAGEN, Agilent Technologies, Hologic, Novartis, Roche, and Genomic Health. These companies invest heavily in research and development to innovate and deliver high-quality and accurate testing solutions to healthcare providers.
The prospects for the EGFR Mutation Test industry are promising. With the increasing adoption of targeted therapies and personalized medicine approaches, the demand for EGFR Mutation Test is expected to rise. Additionally, advancements in genetic sequencing technologies and the expanding scope of genomic research are likely to contribute to market growth.
In conclusion, the EGFR Mutation Test industry is witnessing substantial growth, driven by the rising prevalence of cancer, increasing adoption of personalized medicine, and technological advancements. The EGFR Mutation Test plays a critical role in guiding treatment decisions and improving patient outcomes. With a projected market size of US$738.7 million by 2022, the industry holds significant prospects for both manufacturers and end-users.
The SWOT analysis of the EGFR Mutation Test industry is as follows:
Strengths:
1. Growing demand: There is a growing demand for EGFR mutation tests, primarily due to the increasing prevalence of lung cancer and the need for targeted therapies. This demand is expected to remain strong in the future.
2. Technological advancements: The EGFR mutation test industry has benefited from technological advancements, such as the development of more accurate and efficient testing methods. These advancements have improved the accuracy and speed of test results, leading to better patient outcomes.
3. Established market players: There are several established companies in the EGFR mutation test industry with strong brand recognition and market presence. These companies have the resources and expertise to invest in research and development, ensuring the continued advancement of the industry.
4. Support from regulatory bodies: Regulatory bodies such as the U.S. Food and Drug Administration (FDA) have approved several EGFR mutation tests, providing validation and ensuring the quality and efficacy of these tests. This support from regulatory bodies enhances the credibility and trust in the industry.
Weaknesses:
1. High cost: EGFR mutation tests can be expensive, which may limit access to these tests for some patients. The high cost may be a barrier to widespread adoption in certain regions or healthcare systems with limited resources.
2. Complex reimbursement process: The reimbursement process for EGFR mutation tests can be complex and vary by region or insurance provider. This complexity can result in delays in reimbursement for healthcare providers, affecting their willingness to offer these tests to patients.
3. Limited awareness: Despite the growing demand, there may still be limited awareness among healthcare professionals and patients about the importance of EGFR mutation testing in lung cancer treatment. This lack of awareness can hinder the adoption of these tests and their potential benefits in guiding targeted therapies.
4. Competition: The EGFR mutation test industry is highly competitive, with many companies offering similar testing services. This competition can lead to price pressures and may require companies to continually innovate and differentiate their offerings to maintain market share.
Opportunities:
1. Emerging markets: There is significant growth potential in emerging markets, where the prevalence of lung cancer is increasing, and there is a growing demand for more advanced diagnostics and therapies. Expanding into these markets can provide new growth opportunities for companies in the EGFR mutation test industry.
2. Development of companion diagnostics: The development of companion diagnostics, which are tests specifically designed to determine the likelihood of response to a particular therapy, presents an opportunity for the EGFR mutation test industry. By partnering with pharmaceutical companies, EGFR mutation test providers can play a crucial role in guiding targeted therapy selection.
3. Integration of genomic data: Advances in genomic sequencing and bioinformatics allow for the integration of genomic data into patient management. EGFR mutation test providers can explore collaborations and partnerships to leverage these advancements and provide more comprehensive patient solutions.
4. Personalized medicine: The trend towards personalized medicine is expected to continue, with a focus on tailoring treatment options based on individual patient characteristics. EGFR mutation tests can play a key role in this personalized approach, providing essential information about a patient's specific tumor profile to guide treatment decisions.
Threats:
1. Regulatory challenges: Changes in regulations or guidelines related to EGFR mutation testing can impact the industry. Companies need to stay abreast of regulatory changes and ensure compliance to mitigate these risks.
2. Competition from alternative testing methods: While EGFR mutation tests are currently the standard of care for lung cancer patients, the emergence of alternative testing methods, such as liquid biopsies or next-generation sequencing, could pose a threat to the EGFR mutation test industry. Companies need to stay innovative and adaptable to stay relevant in the face of evolving technologies.
3. Intellectual property challenges: Intellectual property disputes or challenges can arise in the EGFR mutation test industry, particularly in relation to patented technologies or biomarkers. These challenges can disrupt business operations and impact market share.
4. Economic factors: Economic factors, such as reimbursement cuts or changes in healthcare spending, can impact the profitability of the EGFR mutation test industry. Changes in healthcare policies or budgetary constraints can limit the availability of these tests, affecting market growth.
Key players in global EGFR Mutation Test market include:
Abbott
Merck
Thermo Fisher Scientific
Illumina
BioMerieux
QIAGEN
Agilent Technologies
Hologic
Novartis
Roche
Genomic Health
Market segmentation, by product types:
DNA Sequencing
Kits
Market segmentation, by applications:
Cancer Hospitals
Clinical Research Institutes
1 Industry Overview of EGFR Mutation Test
1.1 Research Scope
1.2 Market Segmentation by Types of EGFR Mutation Test
1.3 Market Segmentation by End Users of EGFR Mutation Test
1.4 Market Dynamics Analysis of EGFR Mutation Test
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of EGFR Mutation Test Industry
2.1 Abbott
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Merck
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Thermo Fisher Scientific
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Illumina
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 BioMerieux
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 QIAGEN
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 Agilent Technologies
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 Hologic
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 Novartis
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Roche
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.10.4 Contact Information
2.11 Genomic Health
2.11.1 Company Overview
2.11.2 Main Products and Specifications
2.11.3 EGFR Mutation Test Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.11.4 Contact Information
3 Global EGFR Mutation Test Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Volume and Revenue of EGFR Mutation Test by Regions (2018-2023)
3.2 Global Sales Volume and Revenue of EGFR Mutation Test by Manufacturers (2018-2023)
3.3 Global Sales Volume and Revenue of EGFR Mutation Test by Types (2018-2023)
3.4 Global Sales Volume and Revenue of EGFR Mutation Test by End Users (2018-2023)
3.5 Selling Price Analysis of EGFR Mutation Test by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America EGFR Mutation Test Market Analysis by Countries, Types and End Users
4.1 Northern America EGFR Mutation Test Sales Volume and Revenue Analysis by Countries (2018-2023)
4.2 Northern America EGFR Mutation Test Sales Volume and Revenue Analysis by Types (2018-2023)
4.3 Northern America EGFR Mutation Test Sales Volume and Revenue Analysis by End Users (2018-2023)
4.4 United States EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
4.5 Canada EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe EGFR Mutation Test Market Analysis by Countries, Types and End Users
5.1 Europe EGFR Mutation Test Sales Volume and Revenue Analysis by Countries (2018-2023)
5.2 Europe EGFR Mutation Test Sales Volume and Revenue Analysis by Types (2018-2023)
5.3 Europe EGFR Mutation Test Sales Volume and Revenue Analysis by End Users (2018-2023)
5.4 Germany EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.5 France EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.6 UK EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.7 Italy EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.8 Russia EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.9 Spain EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.10 Netherlands EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific EGFR Mutation Test Market Analysis by Countries, Types and End Users
6.1 Asia Pacific EGFR Mutation Test Sales Volume and Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific EGFR Mutation Test Sales Volume and Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific EGFR Mutation Test Sales Volume and Revenue Analysis by End Users (2018-2023)
6.4 China EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.5 Japan EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.6 Korea EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.7 India EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.8 Australia EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.9 Indonesia EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.10 Vietnam EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America EGFR Mutation Test Market Analysis by Countries, Types and End Users
7.1 Latin America EGFR Mutation Test Sales Volume and Revenue Analysis by Countries (2018-2023)
7.2 Latin America EGFR Mutation Test Sales Volume and Revenue Analysis by Types (2018-2023)
7.3 Latin America EGFR Mutation Test Sales Volume and Revenue Analysis by End Users (2018-2023)
7.4 Brazil EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.5 Mexico EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.6 Argentina EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.7 Colombia EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa EGFR Mutation Test Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa EGFR Mutation Test Sales Volume and Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa EGFR Mutation Test Sales Volume and Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa EGFR Mutation Test Sales Volume and Revenue Analysis by End Users (2018-2023)
8.4 Turkey EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.5 Saudi Arabia EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.6 South Africa EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.7 Egypt EGFR Mutation Test Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global EGFR Mutation Test Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Volume and Revenue Forecast of EGFR Mutation Test by Regions (2024-2029)
10.2 Global Sales Volume and Revenue Forecast of EGFR Mutation Test by Types (2024-2029)
10.3 Global Sales Volume and Revenue Forecast of EGFR Mutation Test by End Users (2024-2029)
10.4 Global Revenue Forecast of EGFR Mutation Test by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of EGFR Mutation Test
11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of EGFR Mutation Test
11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of EGFR Mutation Test
11.1.2 Major Equipment Suppliers with Contact Information Analysis of EGFR Mutation Test
11.2 Downstream Major Consumers Analysis of EGFR Mutation Test
11.3 Major Suppliers of EGFR Mutation Test with Contact Information
11.4 Supply Chain Relationship Analysis of EGFR Mutation Test
12 EGFR Mutation Test New Project Investment Feasibility Analysis
12.1 EGFR Mutation Test New Project SWOT Analysis
12.2 EGFR Mutation Test New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 EGFR Mutation Test Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of EGFR Mutation Test
Table End Users of EGFR Mutation Test
Figure Market Drivers Analysis of EGFR Mutation Test
Figure Market Challenges Analysis of EGFR Mutation Test
Figure Market Opportunities Analysis of EGFR Mutation Test
Table Market Drivers Analysis of EGFR Mutation Test
Table Abbott Information List
Figure EGFR Mutation Test Picture and Specifications of Abbott
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Abbott (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Abbott (2018-2023)
Table Merck Information List
Figure EGFR Mutation Test Picture and Specifications of Merck
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Merck (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Merck (2018-2023)
Table Thermo Fisher Scientific Information List
Figure EGFR Mutation Test Picture and Specifications of Thermo Fisher Scientific
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Thermo Fisher Scientific (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Thermo Fisher Scientific (2018-2023)
Table Illumina Information List
Figure EGFR Mutation Test Picture and Specifications of Illumina
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Illumina (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Illumina (2018-2023)
Table BioMerieux Information List
Figure EGFR Mutation Test Picture and Specifications of BioMerieux
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of BioMerieux (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of BioMerieux (2018-2023)
Table QIAGEN Information List
Figure EGFR Mutation Test Picture and Specifications of QIAGEN
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of QIAGEN (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of QIAGEN (2018-2023)
Table Agilent Technologies Information List
Figure EGFR Mutation Test Picture and Specifications of Agilent Technologies
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Agilent Technologies (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Agilent Technologies (2018-2023)
Table Hologic Information List
Figure EGFR Mutation Test Picture and Specifications of Hologic
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Hologic (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Hologic (2018-2023)
Table Novartis Information List
Figure EGFR Mutation Test Picture and Specifications of Novartis
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Novartis (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Novartis (2018-2023)
Table Roche Information List
Figure EGFR Mutation Test Picture and Specifications of Roche
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Roche (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Roche (2018-2023)
Table Genomic Health Information List
Figure EGFR Mutation Test Picture and Specifications of Genomic Health
Table EGFR Mutation Test Sales Volume, Price, Cost, Gross, Revenue (Million USD) and Gross Margin of Genomic Health (2018-2023)
Figure EGFR Mutation Test Sales Volume and Global Market Share of Genomic Health (2018-2023)
Table Global Sales Volume of EGFR Mutation Test by Regions (2018-2023)
Table Global Revenue (Million USD) of EGFR Mutation Test by Regions (2018-2023)
Table Global Sales Volume of EGFR Mutation Test by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of EGFR Mutation Test by Manufacturers (2018-2023)
Table Global Sales Volume of EGFR Mutation Test by Types (2018-2023)
Table Global Revenue (Million USD) of EGFR Mutation Test by Types (2018-2023)
Table Global Sales Volume of EGFR Mutation Test by End Users (2018-2023)
Table Global Revenue (Million USD) of EGFR Mutation Test by End Users (2018-2023)
Table Selling Price Comparison of Global EGFR Mutation Test by Regions in (2018-2023)
Table Selling Price Comparison of Global EGFR Mutation Test by Manufacturers in (2018-2023)
Table Selling Price Comparison of Global EGFR Mutation Test by Types in (2018-2023)
Table Selling Price Comparison of Global EGFR Mutation Test by End Users in (2018-2023)
Table Northern America EGFR Mutation Test Sales Volume by Countries (2018-2023)
Table Northern America EGFR Mutation Test Revenue (Million USD) by Countries (2018-2023)
Table Northern America EGFR Mutation Test Sales Volume by Types (2018-2023)
Table Northern America EGFR Mutation Test Revenue (Million USD) by Types (2018-2023)
Table Northern America EGFR Mutation Test Sales Volume by End Users (2018-2023)
Table Northern America EGFR Mutation Test Revenue (Million USD) by End Users (2018-2023)
Table United States EGFR Mutation Test Import and Export (2018-2023)
Figure United States EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure United States EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Canada EGFR Mutation Test Import and Export (2018-2023)
Figure Canada EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Canada EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe EGFR Mutation Test Sales Volume by Countries (2018-2023)
Table Europe EGFR Mutation Test Revenue (Million USD) by Countries (2018-2023)
Table Europe EGFR Mutation Test Sales Volume by Types (2018-2023)
Table Europe EGFR Mutation Test Revenue (Million USD) by Types (2018-2023)
Table Europe EGFR Mutation Test Sales Volume by End Users (2018-2023)
Table Europe EGFR Mutation Test Revenue (Million USD) by End Users (2018-2023)
Table Germany EGFR Mutation Test Import and Export (2018-2023)
Figure Germany EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Germany EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table France EGFR Mutation Test Import and Export (2018-2023)
Figure France EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure France EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table UK EGFR Mutation Test Import and Export (2018-2023)
Figure UK EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure UK EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Italy EGFR Mutation Test Import and Export (2018-2023)
Figure Italy EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Italy EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Russia EGFR Mutation Test Import and Export (2018-2023)
Figure Russia EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Russia EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Spain EGFR Mutation Test Import and Export (2018-2023)
Figure Spain EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Spain EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Netherlands EGFR Mutation Test Import and Export (2018-2023)
Figure Netherlands EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Netherlands EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific EGFR Mutation Test Sales Volume by Countries (2018-2023)
Table Asia Pacific EGFR Mutation Test Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific EGFR Mutation Test Sales Volume by Types (2018-2023)
Table Asia Pacific EGFR Mutation Test Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific EGFR Mutation Test Sales Volume by End Users (2018-2023)
Table Asia Pacific EGFR Mutation Test Revenue (Million USD) by End Users (2018-2023)
Table China EGFR Mutation Test Import and Export (2018-2023)
Figure China EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure China EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Japan EGFR Mutation Test Import and Export (2018-2023)
Figure Japan EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Japan EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Korea EGFR Mutation Test Import and Export (2018-2023)
Figure Korea EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Korea EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table India EGFR Mutation Test Import and Export (2018-2023)
Figure India EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure India EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Australia EGFR Mutation Test Import and Export (2018-2023)
Figure Australia EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Australia EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Indonesia EGFR Mutation Test Import and Export (2018-2023)
Figure Indonesia EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Indonesia EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Vietnam EGFR Mutation Test Import and Export (2018-2023)
Figure Vietnam EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Vietnam EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America EGFR Mutation Test Sales Volume by Countries (2018-2023)
Table Latin America EGFR Mutation Test Revenue (Million USD) by Countries (2018-2023)
Table Latin America EGFR Mutation Test Sales Volume by Types (2018-2023)
Table Latin America EGFR Mutation Test Revenue (Million USD) by Types (2018-2023)
Table Latin America EGFR Mutation Test Sales Volume by End Users (2018-2023)
Table Latin America EGFR Mutation Test Revenue (Million USD) by End Users (2018-2023)
Table Brazil EGFR Mutation Test Import and Export (2018-2023)
Figure Brazil EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Brazil EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Mexico EGFR Mutation Test Import and Export (2018-2023)
Figure Mexico EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Mexico EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Argentina EGFR Mutation Test Import and Export (2018-2023)
Figure Argentina EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Argentina EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Colombia EGFR Mutation Test Import and Export (2018-2023)
Figure Colombia EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Colombia EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa EGFR Mutation Test Sales Volume by Countries (2018-2023)
Table Middle East & Africa EGFR Mutation Test Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa EGFR Mutation Test Sales Volume by Types (2018-2023)
Table Middle East & Africa EGFR Mutation Test Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa EGFR Mutation Test Sales Volume by End Users (2018-2023)
Table Middle East & Africa EGFR Mutation Test Revenue (Million USD) by End Users (2018-2023)
Table Turkey EGFR Mutation Test Import and Export (2018-2023)
Figure Turkey EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Turkey EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Saudi Arabia EGFR Mutation Test Import and Export (2018-2023)
Figure Saudi Arabia EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Saudi Arabia EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table South Africa EGFR Mutation Test Import and Export (2018-2023)
Figure South Africa EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure South Africa EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Egypt EGFR Mutation Test Import and Export (2018-2023)
Figure Egypt EGFR Mutation Test Sales Volume and Growth Rate (2018-2023)
Figure Egypt EGFR Mutation Test Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Sales Volume Forecast of EGFR Mutation Test by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of EGFR Mutation Test by Regions (2024-2029)
Table Global Sales Volume Forecast of EGFR Mutation Test by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of EGFR Mutation Test by Types (2024-2029)
Table Global Sales Volume Forecast of EGFR Mutation Test by End Users (2024-2029)
Table Global Revenue (Million USD) Forecast of EGFR Mutation Test by End Users (2024-2029)
Table Major Raw Materials Suppliers with Contact Information of EGFR Mutation Test
Table Major Equipment Suppliers with Contact Information of EGFR Mutation Test
Table Major Consumers with Contact Information of EGFR Mutation Test
Table Major Suppliers of EGFR Mutation Test with Contact Information
Figure Supply Chain Relationship Analysis of EGFR Mutation Test
Table New Project SWOT Analysis of EGFR Mutation Test
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of EGFR Mutation Test
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of EGFR Mutation Test Industry
Table Part of References List of EGFR Mutation Test Industry
Table Units of Measurement List
Table Part of Author Details List of EGFR Mutation Test Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the EGFR Mutation Test industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the EGFR Mutation Test market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from EGFR Mutation Test manufacturers, EGFR Mutation Test raw material suppliers, EGFR Mutation Test distributors as well as buyers. The primary sources from the supply side include EGFR Mutation Test manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the EGFR Mutation Test raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: EGFR Mutation Test industry landscape and trends, EGFR Mutation Test market dynamics and key issues, EGFR Mutation Test technology landscape, market opportunities, porter’s analysis and PESTEL analysis, EGFR Mutation Test competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: EGFR Mutation Test market size and forecast by regions, EGFR Mutation Test market size and forecast by application, EGFR Mutation Test market size and forecast by types, EGFR Mutation Test company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
